New Search

If you are not happy with the results below please do another search

36 search results for:

12

Boost your gen AI ROI: Scaling AI projects multiplies returns

Boost Your ROI: Scaling AI Projects Multiplies Returns Successfully scaling generative AI projects can significantly boost your ROI. While initial returns from pilot projects may be limited, scaling these initiatives can yield three times the return compared to those that never move beyond the pilot stage. For every dollar invested in AI, companies see an [...]
13

ONERAY.AI Capability Update: Document Summarization & Discussion

ONERAY.AI capability update Exciting update! Our private Hashtag#generativeAI solution OneRay.AI, co-created with Pharma and Biotech partners just released a capability update. This state-of-the-art tool now offers ad-hoc summarization and discussion for up to 5 documents simultaneously in a secure, Pharma-compliant environment. It supports multiple formats, including images and graphs, and validates with Hashtag#Veeva and approved [...]
14

Competencies that drive impact in Rare Diseases

Competencies that drive impact in Rare Disease We contribute to the management of rare diseases by fostering collaboration between life-science companies, patients, and support networks at global scale. The journey to diagnose a rare disease often spans 6 to 8 years due to the complexity and rarity of these conditions, often compounded by misdiagnoses and [...]
15

FFI generative AI framework & key services

FFI generative AI framework & key services Ready to unlock the impact of #GenAI this summer? With over 18 months of diverse experience, FFI can rapidly support your organization in maximizing AI value creation. From strategy and governance to execution, we guide you through every step - including setting up your custom, private #GenerativeAI environment. [...]
16

Maximizing ROI in Pharma: A Deep Dive into AI Use Case Prioritization

Maximizing ROI in Pharma: A Deep Dive into AI Use Case Prioritization The prioritization grid for generative AI use cases in the pharmaceutical industry provides a comprehensive overview of various use cases FFI-Ventures is working on today and within the last 18 months. The grid outlines the potential business impact, and technical feasibility of use [...]
17

FFI has a broad spectrum of capabilities

FFI has broad spectrum of capabilities We're talking a lot about Hashtag#genAI but Hashtag#FFI goes beyond AI scaling in Pharma. We offer a unique blend of global and local expertise, combining innovative strategies with practical execution. Across Pharma, Medtech & Biotech functions, our approach and team delivers significant results & value-add. Discover how FFI can [...]
18

Ramping-up private gen AI within Pharma and Medtech organizations

Ramping-up private gen AI within Pharma and Medtech organizations Especially for medical and commercial organizations, the integration of private bespoke generative AI solutions is becoming a game-changer. This blog post explores the strategic approach to implementing tailored AI solutions in the pharma industry, highlighting how FFI-Ventures can support organizations throughout this transformative journey. The step-wise [...]
19

Key Takeaways for Generative AI Adoption

Key Takeaways for Gen AI Adoption With about 70 participants, the first Swiss AI Forum under the philosophy “from pharma for pharma” was a success and underlined the interest of Pharma and Biotech in tangible best practices to better achieve business objectives by applying generative AI solutions. For this occasion, the swiss health quality association [...]
20

Reflections on the Data+AI summit June 12/13, 2024

Reflections on the Data+AI summit June 12/13, 2024 The Data+AI summit organized by Databricks in San Francisco yielded very valuable insights that supplement our learnings from work with more than 15 pharma and biotech organizations. Key themes that I took away: 1. Generative AI has confirmed potential, delivers value and can be a game changer [...]